Skip to content
Article Rich – Lifestyle
Author:
Day One Biopharmaceuticals, Inc.
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
March 6, 2026
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
March 4, 2026